Real Progressives,
Phase 1 data from alisertib reduced bone marrow fibrosis in 5 of 7 patients on the drug as well as improving symptoms, spleen…
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial
Overview of attention for article published in Clinical Cancer Research, August 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Readers on
- mendeley
- 48 Mendeley